Global Non-melanoma Skin Cancer Market 2018-2022
SKU ID : TNV-13687818 | Publishing Date : 29-Nov-2018 | No. of pages : 103
Detailed TOC of Global Non-melanoma Skin Cancer Market 2018-2022
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: PIPELINE ANALYSIS
• NMSC pipeline
PART 06: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• The threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 08: MARKET SEGMENTATION BY TYPE OF NMSC
• Segmentation by type of NMSC
• Comparison by type of NMSC
• BCC – Market size and forecast 2017-2022
• SCC – Market size and forecast 2017-2022
• Market opportunity by type of NMSC
PART 09: MARKET SEGMENTATION BY THERAPY
• Segmentation by therapy
PART 10: CUSTOMER LANDSCAPE
PART 11: REGIONAL LANDSCAPE
• Geographical Segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 14: MARKET TRENDS
• Increasing incidence of NMSC
• Surgery considered as a first-line curative approach for NMSC
• High off-label use of topical treatments for NMSC
• Low physician adherence to NMSC diagnostic and treatment guidelines
PART 15: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 16: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bausch Health
• F. Hoffmann-La Roche
• Sun Pharmaceuticals
• 3M Pharmaceuticals
PART 17: APPENDIX
List of abbreviations
Exhibit 01: Global NMSC market
Exhibit 02: Global oncology market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Type of NMSC – Market share 2017-2022 (%)
Exhibit 19: Comparison by type of NMSC
Exhibit 20: BCC – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: BCC – Year-over-year growth 2018-2022 (%)
Exhibit 22: SCC – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: SCC – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by type of NMSC
Exhibit 25: Customer landscape
Exhibit 26: Global – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top 3 countries in Americas
Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in EMEA
Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Bausch Health – Overview
Exhibit 44: Bausch Health – Business segments
Exhibit 45: Bausch Health – Organizational developments
Exhibit 46: Bausch Health – Geographic focus
Exhibit 47: Bausch Health – Segment focus
Exhibit 48: Bausch Health – Key offerings
Exhibit 49: F. Hoffmann-La Roche – Overview
Exhibit 50: F. Hoffmann-La Roche – Business segments
Exhibit 51: F. Hoffmann-La Roche – Organizational developments
Exhibit 52: F. Hoffmann-La Roche – Geographic focus
Exhibit 53: F. Hoffmann-La Roche – Segment focus
Exhibit 54: F. Hoffmann-La Roche – Key offerings
Exhibit 55: Sun Pharmaceuticals – Overview
Exhibit 56: Sun Pharmaceuticals – Business segments
Exhibit 57: Sun Pharmaceuticals – Organizational developments
Exhibit 58: Sun Pharmaceuticals – Geographic focus
Exhibit 59: Sun Pharmaceuticals – Segment focus
Exhibit 60: Sun Pharmaceuticals – Key offerings
Exhibit 61: M Pharmaceuticals – Overview
Exhibit 62: M Pharmaceuticals – Business segments
Exhibit 63: M Pharmaceuticals – Organizational developments
Exhibit 64: M Pharmaceuticals – Geographic focus
Exhibit 65: M Pharmaceuticals – Segment focus
Exhibit 66: M Pharmaceuticals – Key offerings
Keyplayers in Global Non-melanoma Skin Cancer Market 2018-2022
Bausch HealthF. Hoffmann-La Roche
Sun Pharmaceuticals
3M Pharmaceuticals